Introduced
Underlined text would be added to current law. Struck-through text would be removed.
| By: Frank | H.B. No. 4586 |
| A BILL TO BE ENTITLED | |
| AN ACT | |
| relating to prohibited direct-to-consumer pharmaceutical | |
| advertising; providing an administrative penalty. | |
| BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS: | |
| SECTION 1. Subchapter E, Chapter 431, Health and Safety | |
| Code, is amended by adding Section 431.118 to read as follows: | |
| Sec. 431.118. PROHIBITED PHARMACEUTICAL ADVERTISING; | |
| ADMINISTRATIVE PENALTY. (a) In this section, "direct-to-consumer | |
| pharmaceutical advertising" means any promotional communication | |
| targeting consumers including, but not limited to, television, | |
| radio, print media, digital platforms, and social media, that | |
| markets prescription drugs. | |
| (b) No person or entity may engage in direct-to-consumer | |
| pharmaceutical advertising within this state. | |
| (c) The department may assess an administrative penalty | |
| against a person or entity who violates this section or fails to | |
| comply with a rule adopted under this section. The penalty may not | |
| exceed $10,000 a day for each violation. Each day a violation | |
| continues may be considered a separate violation. Except as | |
| otherwise provided by rule, the department must comply with the | |
| administrative penalty procedures described in Subchapter C. | |
| (d) The executive commissioner may adopt rules as necessary | |
| to implement this section. | |
| SECTION 2. This Act takes effect September 1, 2025. |
Official text from the Texas Legislature. Formatting has been adapted for reading on Ratifi.